Webcasts Home

On Demand Treatment: Putting the ED Patient in the Driver's Seat

Joint Sponsor Statement
Jointly sponsored by Postgraduate Institute for Medicine and CME Incite.

Postgraduate Institute for Medicine CME INCITE

Funding Statement
This activity is supported by an independent educational grant from Vivus.

VIVUS  

Release Date: August 6, 2012
Expiration Date: August 31, 2013

Estimated time to complete activity: 2 hours

Media: Internet

Intended Audience
This CME-certified activity is designed to meet the educational needs of urologists who treat patients suffering from erectile dysfunction (ED).

Program Overview
ED affects up to 18 million men in the United States. Introduced in 1998, phosphodiesterase type 5 (PDE5) inhibitors are now considered the standard for initial first-line treatment for ED. Current PDE5 inhibitors are used to treat a broad range of patients and their spectrum of ED symptoms. Many men, however, experience unwanted adverse effects due to the lack of specificity for the PDE5 isoenzyme.

With several PDE5 inhibitors from which to choose and a new agent on the horizon, it is essential to inform urologists and other clinicians about the differentiating characteristics of each therapy.

This interactive, case-based webcast will allow physicians to implement a treatment strategy based on the individual patient's needs, rather than taking a "one-size-fits-all" approach. Older men, young men, and difficult-to-treat patient populations have different needs and should be evaluated carefully. The safety and efficacy of the PDE5 inhibitors as well as specificity of agents and drug-drug interactions should also be evaluated before prescribing a PDE5 inhibitor.

Learning Objectives
Upon completion of this educational activity, participants should be better able to:

Chairperson:
John Mulhall, MD
President, Sexual Medicine Society of North America
Director, Sexual and Reproductive Medicine Program, Division of Urology
Memorial Sloan-Kettering Cancer Center
New York, NY

Faculty:
Arthur L. Burnett, MD, MBA, FACS
Patrick C. Walsh Professor of Urology, Cellular and Molecular Medicine
The James Buchanan Brady Urological Institute
The Johns Hopkins Medical Institutions
Baltimore, MD

Wayne J.G. Hellstrom, MD, FACS
Chief, Section of Andrology
Tulane University School of Medicine
New Orleans, LA

Francesco Montorsi, MD
Professor of Urology
Director, Urological Research Institute
Vita Salute San Raffaele University
Milan, Italy

ACCME Accreditation Statement
Physician Continuing Education

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and CME Incite. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Fee Information
There is no fee for this educational activity.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity.

John Mulhall, MD

Arthur L. Burnett, MD, MBA, FACS

Wayne J.G. Hellstrom, MD, FACS

Francesco Montorsi, MD

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity.

The following PIM planners and managers: Laura Excell, ND, NP, MS, MA, LPC, NCC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD, Jan Schultz, RN, MSN, CCMEP, and Patricia Staples, MSN, NP-C, CCRN hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. Priya Wanchoo, MBBS, and Rose O'Connor, PhD, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Method of Participation and Request for Credit
There are no fees for participating and receiving CME credit for this activity. During the period August 6, 2012 through August 31, 2013, participants must read the learning objectives and faculty disclosures and study the educational activity.

PIM supports Green CME by offering your Request for Credit online. If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. On the navigation menu under course links, click on "Find Evaluation/Post-test" then Find Evaluation 8748. Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately. Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.

Hardware and Software Requirements
This Webcast requires a modern Web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome).

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. PIM, CME Incite, and Vivus do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, CME Incite, and Vivus. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.